|
|
||||||||
(slow)-isoform of MHC in the adult mouse
heart causes dominant-negative functional effects
1 Department of Medicine, Albert Einstein College of Medicine, Bronx 10461; 3 State University of New York, Health Science Center, Syracuse 13210;2 Division of Molecular Cardiovascular Biology, Department of Pediatrics, Children's Hospital Research Foundation, Cincinnati, Ohio 45229; and 4 Department of Molecular, Cellular and Developmental Biology, University of Colorado, Boulder, Colorado 80309
- and
-myosin heavy chain (MHC),
the two MHC isoforms expressed in the mammalian heart, differ
quantitatively in their enzymatic activities. The MHC composition of
the heart can change dramatically in response to numerous stimuli,
leading to the hypothesis that changes in cardiac function can be
caused by myosin isoform shifts. However, this hypothesis has remained
unproven because the stimuli used to generate these shifts are complex
and accompanied by many additional physiological changes, including
alterations in cardiac mass and geometry. Adult mouse ventricles
normally express only
-MHC (the faster motor). To determine whether
genetic alteration of the MHC isoform composition in the adult mouse
heart would result in changes in cardiac chamber mass and
contractility, we established transgenic mouse lines that express a
Myc-tagged
-MHC molecule (the slower motor) in adult ventricular
tissue, one of which expreses 12% of its myosin as the transgene.
There is no evidence of hypertrophy, induction of hypertrophic markers,
and no histopathology. Myofibrillar
Ca2+-activated ATPase activity is
decreased by 23%, and Langendorff preparations demonstrate a
significant 15% decrease in systolic function in transgenic hearts.
These results suggest that even small shifts in the myosin isoform
composition of the myocardium can result in physiologically significant
changes in cardiac contractility and could be relevant to
cardiovascular disease.
myosin heavy chain; contractility; transgenic
This article has been cited by other articles:
![]() |
J. Davis, M. V. Westfall, D. Townsend, M. Blankinship, T. J. Herron, G. Guerrero-Serna, W. Wang, E. Devaney, and J. M. Metzger Designing Heart Performance by Gene Transfer Physiol Rev, October 1, 2008; 88(4): 1567 - 1651. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Colson, T. Bekyarova, M. R. Locher, D. P. Fitzsimons, T. C. Irving, and R. L. Moss Protein Kinase A-Mediated Phosphorylation of cMyBP-C Increases Proximity of Myosin Heads to Actin in Resting Myocardium Circ. Res., August 1, 2008; 103(3): 244 - 251. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Hydock, C.-Y. Lien, C. M. Schneider, and R. Hayward Effects of voluntary wheel running on cardiac function and myosin heavy chain in chemically gonadectomized rats Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3254 - H3264. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. F. Martin, S. Bhatti, G. J. Pyne-Geithman, M. Farjah, V. Manaves, L. Walker, R. Franks, A. R. Strauch, and R. J. Paul Expression and function of COOH-terminal myosin heavy chain isoforms in mouse smooth muscle Am J Physiol Cell Physiol, July 1, 2007; 293(1): C238 - C245. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Herron, R. Vandenboom, E. Fomicheva, L. Mundada, T. Edwards, and J. M. Metzger Calcium-Independent Negative Inotropy by {beta}-Myosin Heavy Chain Gene Transfer in Cardiac Myocytes Circ. Res., April 27, 2007; 100(8): 1182 - 1190. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. G. Laustsen, S. J. Russell, L. Cui, A. Entingh-Pearsall, M. Holzenberger, R. Liao, and C. R. Kahn Essential Role of Insulin and Insulin-Like Growth Factor 1 Receptor Signaling in Cardiac Development and Function Mol. Cell. Biol., March 1, 2007; 27(5): 1649 - 1664. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Stelzer, S. L. Brickson, M. R. Locher, and R. L. Moss Role of myosin heavy chain composition in the stretch activation response of rat myocardium J. Physiol., February 15, 2007; 579(1): 161 - 173. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Tschirgi, I. Rajapakse, and M. Chandra Functional consequence of mutation in rat cardiac troponin T is affected differently by myosin heavy chain isoforms J. Physiol., July 1, 2006; 574(1): 263 - 273. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Sun, B.-G. Kerfant, D. Zhao, M. G. Trivieri, G. Y. Oudit, J. M. Penninger, and P. H. Backx Insulin-Like Growth Factor-1 and PTEN Deletion Enhance Cardiac L-Type Ca2+ Currents via Increased PI3K{alpha}/PKB Signaling Circ. Res., June 9, 2006; 98(11): 1390 - 1397. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Konhilas, P. A. Watson, A. Maass, D. M. Boucek, T. Horn, B. L. Stauffer, S. W. Luckey, P. Rosenberg, and L. A. Leinwand Exercise Can Prevent and Reverse the Severity of Hypertrophic Cardiomyopathy Circ. Res., March 3, 2006; 98(4): 540 - 548. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Backs and E. N. Olson Control of Cardiac Growth by Histone Acetylation/Deacetylation Circ. Res., January 6, 2006; 98(1): 15 - 24. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Emter, S. A. McCune, G. C. Sparagna, M. J. Radin, and R. L. Moore Low-intensity exercise training delays onset of decompensated heart failure in spontaneously hypertensive heart failure rats Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H2030 - H2038. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Pelzer, V. Jazbutyte, K. Hu, S. Segerer, M. Nahrendorf, P. Nordbeck, A. W. Bonz, J. Muck, K.-H. Fritzemeier, C. Hegele-Hartung, et al. The estrogen receptor-{alpha} agonist 16{alpha}-LE2 inhibits cardiac hypertrophy and improves hemodynamic function in estrogen-deficient spontaneously hypertensive rats Cardiovasc Res, September 1, 2005; 67(4): 604 - 612. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Dewald, S. Sharma, J. Adrogue, R. Salazar, G. D. Duerr, J. D. Crapo, M. L. Entman, and H. Taegtmeyer Downregulation of Peroxisome Proliferator-Activated Receptor-{alpha} Gene Expression in a Mouse Model of Ischemic Cardiomyopathy Is Dependent on Reactive Oxygen Species and Prevents Lipotoxicity Circulation, July 19, 2005; 112(3): 407 - 415. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. James, L. Martin, M. Krenz, C. Quatman, F. Jones, R. Klevitsky, J. Gulick, and J. Robbins Forced Expression of {alpha}-Myosin Heavy Chain in the Rabbit Ventricle Results in Cardioprotection Under Cardiomyopathic Conditions Circulation, May 10, 2005; 111(18): 2339 - 2346. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. L. M. Rundell, V. Manaves, A. F. Martin, and P. P. de Tombe Impact of {beta}-myosin heavy chain isoform expression on cross-bridge cycling kinetics Am J Physiol Heart Circ Physiol, February 1, 2005; 288(2): H896 - H903. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Sucharov, S. M. Helmke, S. J. Langer, M. B. Perryman, M. Bristow, and L. Leinwand The Ku Protein Complex Interacts with YY1, Is Up-Regulated in Human Heart Failure, and Represses {alpha} Myosin Heavy-Chain Gene Expression Mol. Cell. Biol., October 1, 2004; 24(19): 8705 - 8715. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Olsson, B. M. Palmer, B. L. Stauffer, L. A. Leinwand, and R. L. Moore Morphological and Functional Alterations in Ventricular Myocytes From Male Transgenic Mice With Hypertrophic Cardiomyopathy Circ. Res., February 6, 2004; 94(2): 201 - 207. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhong, P. J Reiser, and M. A. Matlib Gender differences in myosin heavy chain-{beta} and phosphorylated phospholamban in diabetic rat hearts Am J Physiol Heart Circ Physiol, December 1, 2003; 285(6): H2688 - H2693. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ishibashi, M. Takahashi, Y. Isomatsu, F. Qiao, Y. Iijima, H. Shiraishi, J. M. Simsic, C. F. Baicu, J. Robbins, M. R. Zile, et al. Role of microtubules versus myosin heavy chain isoforms in contractile dysfunction of hypertrophied murine cardiocytes Am J Physiol Heart Circ Physiol, August 7, 2003; 285(3): H1270 - H1285. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Krenz, A. Sanbe, F. Bouyer-Dalloz, J. Gulick, R. Klevitsky, T. E. Hewett, H. E. Osinska, J. N. Lorenz, C. Brosseau, A. Federico, et al. Analysis of Myosin Heavy Chain Functionality in the Heart J. Biol. Chem., May 2, 2003; 278(19): 17466 - 17474. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. T. Lucas, P. Aryal, L. I. Szweda, W. J. Koch, and L. A. Leinwand Alterations in mitochondrial function in a mouse model of hypertrophic cardiomyopathy Am J Physiol Heart Circ Physiol, February 1, 2003; 284(2): H575 - H583. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G Schmidt, J. Zhai, A. N Carr, M. J Gerst, J. N Lorenz, P. Pollesello, A. Annila, B. D Hoit, and E. G Kranias Structural and functional implications of the phospholamban hinge domain: impaired SR Ca2+ uptake as a primary cause of heart failure Cardiovasc Res, November 1, 2002; 56(2): 248 - 259. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Herron, F. S. Korte, and K. S. McDonald Loaded shortening and power output in cardiac myocytes are dependent on myosin heavy chain isoform expression Am J Physiol Heart Circ Physiol, September 1, 2001; 281(3): H1217 - H1222. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |